12/06/2024
10:36 AM | Applied Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
12/02/2024
4:15 PM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:47 PM | Applied Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
3:50 PM | Applied Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
11/13/2024
3:15 PM | ALEXANDRIA REAL ESTATE EQUITIES, INC. (Filed by)
Applied Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
1:17 PM | Applied Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
11/07/2024
6:30 AM | Applied Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
11/07/2024
6:19 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:38 PM | Applied Therapeutics (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G | |
10/31/2024
11:42 AM | Applied Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G/A | |
10/24/2024
1:02 PM | Applied Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
08/23/2024
3:33 PM | Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
3:35 PM | Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
5:52 PM | Applied Therapeutics (Subject)
Shendelman Shoshana (Filed by)
| Form SC 13D/A | |
08/14/2024
6:01 PM | Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
7:43 PM | Applied Therapeutics (Subject)
Shendelman Shoshana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
6:08 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
6:13 AM | Applied Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/10/2024
3:29 PM | Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:25 PM | Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:12 PM | Applied Therapeutics (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:13 PM | Applied Therapeutics (Issuer)
SKYLER JAY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:17 PM | Applied Therapeutics (Issuer)
Kanter Stacy J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:45 PM | Alexandria Equities No. 7, LLC (Reporting)
ALEXANDRIA REAL ESTATE EQUITIES, INC. (Reporting)
Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:26 PM | Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
5:10 PM | Applied Therapeutics (Subject)
Hansard Adam (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
6:13 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:17 AM | Applied Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
11:15 PM | Applied Therapeutics (Filer)
| Form EFFECT | |
04/25/2024
3:33 PM | Applied Therapeutics (Filer)
| Form 424B3 | |
04/22/2024
3:37 PM | Applied Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:38 PM | Applied Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
3:39 PM | Applied Therapeutics (Filer)
| Form ARS | |
04/15/2024
4:27 PM | Applied Therapeutics (Issuer)
Hooks Corwin Dale (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/15/2024
4:30 PM | Applied Therapeutics (Issuer)
Hooks Corwin Dale (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
4:00 PM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
3:41 PM | Applied Therapeutics (Filer)
| Form PRE 14A | |
03/22/2024
3:31 PM | Applied Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/18/2024
4:57 PM | Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
5:00 PM | Applied Therapeutics (Issuer)
Hansard Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
5:02 PM | Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Why I'm telling friends to avoid gold stocks (Ad) Back in November, gold made a tiny move of 1.6%.
But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week.
It happened again in March. Gold nudged up 1.2%.
This time? A 104% overnight gain.
And in June? A 1% gold move turned into a 74% gain in two weeks.
Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now.
There's a more lucrative way to play the gold market as we enter a new breakout period.
It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. |
03/18/2024
5:12 PM | Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:49 PM | Applied Therapeutics (Issuer)
Chinoporos Constantine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/18/2024
4:51 PM | Applied Therapeutics (Issuer)
Chinoporos Constantine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:42 PM | Applied Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/11/2024
7:17 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
2:17 PM | Applied Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G | |
03/06/2024
6:19 AM | Applied Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
6:12 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
4:42 PM | Applied Therapeutics (Subject)
Shendelman Shoshana (Filed by)
| Form SC 13D/A | |
02/29/2024
3:18 PM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
1:26 PM | Applied Therapeutics (Subject)
Propel Bio Management, LLC (Filed by)
| Form SC 13G/A | |
02/15/2024
6:07 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:20 PM | Applied Therapeutics (Subject)
Applied Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
5:30 PM | Applied Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
3:22 PM | ALEXANDRIA REAL ESTATE EQUITIES, INC. (Filed by)
Applied Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
1:40 PM | Applied Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
12:50 PM | Alyeska Investment Group, L.P. (Filed by)
Applied Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Applied Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/06/2024
7:49 AM | Applied Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G/A | |
01/03/2024
8:15 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
3:23 PM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
7:01 PM | Applied Therapeutics (Issuer)
Hansard Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
7:01 PM | Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
7:01 PM | Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
